Why the study?
Pulmonary arterial hypertension is associated with high mortality if left untreated, motivating the assessment of prognostic cardiac magnetic resonance features using machine learning.
Does an MPCA-based machine learning approach applied to CMR improve 1-year mortality prediction compared to the REVEAL risk score in treatment-naive PAH patients?
Does an MPCA-based machine learning approach applied to CMR improve 1-year mortality prediction compared to the REVEAL risk score in treatment-naive PAH patients?
An explainable machine learning approach using CMR features significantly improves 1-year mortality prediction over the REVEAL risk score in newly diagnosed PAH patients.
MPCA-CMR features may refine PAH risk stratification; leaves open whether ML models improve outcomes over conventional metrics.
Aims Pulmonary arterial hypertension (PAH) is a rare but serious disease associated with high mortality if left untreated. This study aims to assess the prognostic cardiac magnetic resonance (CMR) features in PAH using machine learning. Methods and results Seven hundred and twenty-three consecutive treatment-naive PAH patients were identified from the ASPIRE registry; 516 were included in the training, and 207 in the validation cohort. A multilinear principal component analysis (MPCA)-based machine learning approach was used to extract mortality and survival features throughout the cardiac cycle. The features were overlaid on the original imaging using thresholding and clustering of high- and low-risk of mortality prediction values. The 1-year mortality rate in the validation cohort was 10%. Univariable Cox regression analysis of the combined short-axis and four-chamber MPCA-based predictions was statistically significant (hazard ratios: 2.1, 95% CI: 1.3, 3.4, c-index = 0.70, P = 0.002). The MPCA features improved the 1-year mortality prediction of REVEAL from c-index = 0.71 to 0.76 (P ≤ 0.001). Abnormalities in the end-systolic interventricular septum and end-diastolic left ventricle indicated the highest risk of mortality. Conclusion The MPCA-based machine learning is an explainable time-resolved approach that allows visualization of prognostic cardiac features throughout the cardiac cycle at the population level, making this approach transparent and clinically interpretable. In addition, the added prognostic value over the REVEAL risk score and CMR volumetric measurements allows for a more accurate prediction of 1-year mortality risk in PAH.
No takes yet. Share an insight, caveat, or question.
Alabed et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: